(19)
(11) EP 4 367 140 A1

(12)

(43) Date of publication:
15.05.2024 Bulletin 2024/20

(21) Application number: 22837100.1

(22) Date of filing: 06.07.2022
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C12N 15/13(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 39/39; C07K 16/2878; C07K 16/2818; C07K 2317/74; C07K 2317/75; C07K 2317/76; C07K 2317/90; C07K 2317/92; C07K 2317/24; C07K 2317/33; C07K 2317/34; C07K 2317/732; A61K 2039/507; A61K 2039/505
(86) International application number:
PCT/IB2022/000409
(87) International publication number:
WO 2023/281313 (12.01.2023 Gazette 2023/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.07.2021 US 202163219175 P

(71) Applicant: Hifibio (HK) Limited
Central (CN)

(72) Inventors:
  • BELTRAMINELLI, Nicola Arturo, Aldo
    Cambridge, MA 02139 (US)
  • WATKINS, Jennifer
    Cambridge, MA 02139 (US)
  • ADRIAN, Francisco
    Cambridge, MA 02139 (US)
  • ZHANG, Qian
    Cambridge, MA 02139 (US)
  • RAUE, Andreas
    Cambridge, MA 02139 (US)
  • MARY, Pascaline
    Cambridge, MA 02139 (US)
  • SCHWEIZER, Liang
    Cambridge, MA 02139 (US)
  • WEI, Shuo
    Cambridge, MA 02139 (US)
  • DELINCE, Matthieu
    Cambridge, MA 02139 (US)

(74) Representative: CH Kilger Anwaltspartnerschaft mbB 
Fasanenstraße 29
10719 Berlin
10719 Berlin (DE)

   


(54) ANTI-TNFR2 ANTIBODY AND USES THEREOF